271 related articles for article (PubMed ID: 34216725)
21. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study.
Buhrmann C; Shayan P; Brockmueller A; Shakibaei M
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962102
[TBL] [Abstract][Full Text] [Related]
23. Next-Generation Porcine Intestinal Organoids: an Apical-Out Organoid Model for Swine Enteric Virus Infection and Immune Response Investigations.
Li Y; Yang N; Chen J; Huang X; Zhang N; Yang S; Liu G; Liu G
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796075
[TBL] [Abstract][Full Text] [Related]
24. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases.
Ceelen W; Ramsay RG; Narasimhan V; Heriot AG; De Wever O
Trends Cancer; 2020 Mar; 6(3):236-246. PubMed ID: 32101726
[TBL] [Abstract][Full Text] [Related]
25. [Establishment of mini-guts organoid and research on intestinal disease from the new perspective].
Xu ZY; Liu Y; Jiang YG; Huang JJ; Wu XW; Ren JA
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):638-643. PubMed ID: 34289550
[TBL] [Abstract][Full Text] [Related]
26. Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review.
DeHaan RK; Sarvestani SK; Huang EH
Dis Colon Rectum; 2020 Nov; 63(11):1559-1569. PubMed ID: 32868555
[TBL] [Abstract][Full Text] [Related]
27. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
28. Translational models of 3-D organoids and cancer stem cells in gastric cancer research.
Wuputra K; Ku CC; Kato K; Wu DC; Saito S; Yokoyama KK
Stem Cell Res Ther; 2021 Sep; 12(1):492. PubMed ID: 34488885
[TBL] [Abstract][Full Text] [Related]
29. Advances in the use of 3D colorectal cancer models for novel drug discovery.
Baião A; Dias S; Soares AF; Pereira CL; Oliveira C; Sarmento B
Expert Opin Drug Discov; 2022 Jun; 17(6):569-580. PubMed ID: 35343351
[TBL] [Abstract][Full Text] [Related]
30. Microphysiological systems to study colorectal cancer: state-of-the-art.
Ramos P; Carvalho MR; Chen W; Yan LP; Zhang CH; He YL; Reis RL; Oliveira JM
Biofabrication; 2023 Apr; 15(3):. PubMed ID: 36888998
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids.
Devarasetty M; Forsythe SD; Shelkey E; Soker S
Tissue Eng Regen Med; 2020 Dec; 17(6):759-771. PubMed ID: 32399776
[TBL] [Abstract][Full Text] [Related]
32. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
[TBL] [Abstract][Full Text] [Related]
33. Organoid in colorectal cancer: progress and challenges.
Ji DB; Wu AW
Chin Med J (Engl); 2020 Aug; 133(16):1971-1977. PubMed ID: 32826461
[TBL] [Abstract][Full Text] [Related]
34. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
Schnalzger TE; de Groot MH; Zhang C; Mosa MH; Michels BE; Röder J; Darvishi T; Wels WS; Farin HF
EMBO J; 2019 Jun; 38(12):. PubMed ID: 31036555
[TBL] [Abstract][Full Text] [Related]
35. From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer.
Betge J; Jackstadt R
Int J Cancer; 2023 Apr; 152(7):1304-1313. PubMed ID: 36121667
[TBL] [Abstract][Full Text] [Related]
36. Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer.
Devarasetty M; Skardal A; Cowdrick K; Marini F; Soker S
Tissue Eng Part A; 2017 Oct; 23(19-20):1026-1041. PubMed ID: 28922975
[TBL] [Abstract][Full Text] [Related]
37. Immuno-genomic classification of colorectal cancer organoids reveals cancer cells with intrinsic immunogenic properties associated with patient survival.
Cho EJ; Kim M; Jo D; Kim J; Oh JH; Chung HC; Lee SH; Kim D; Chun SM; Kim J; Lee H; Kim TW; Yu CS; Sung CO; Jang SJ
J Exp Clin Cancer Res; 2021 Jul; 40(1):230. PubMed ID: 34256801
[TBL] [Abstract][Full Text] [Related]
38. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
39. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract][Full Text] [Related]
40. Preparation and Cultivation of Colonic and Small Intestinal Murine Organoids Including Analysis of Gene Expression and Organoid Viability.
Klemke L; Blume JP; De Oliveira T; Schulz-Heddergott R
Bio Protoc; 2022 Jan; 12(2):e4298. PubMed ID: 35127988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
